Mupirocin and Injection site swelling - a phase IV clinical study of FDA data

Summary:

Injection site swelling is reported as a side effect among people who take Mupirocin (mupirocin), especially for people who are female, 30-39 old, also take Dupixent, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Injection site swelling when taking Mupirocin. It is created by eHealthMe based on reports of 5,867 people who have side effects when taking Mupirocin from the FDA, and is updated regularly.

What is Mupirocin?

Mupirocin has active ingredients of mupirocin. It is often used in impetigo. eHealthMe is studying from 5,940 Mupirocin users. Check the latest studies of Mupirocin.

What is Injection site swelling?

Injection site swelling is found to be associated with 1,061 drugs and 1,115 conditions by eHealthMe. Check the latest studies of Injection site swelling.

On Jul, 06, 2026

5,867 people reported to have side effects when taking Mupirocin.
Among them, 36 people (0.61%) have Injection site swelling.

Could Mupirocin cause Injection site swelling?

Among these 36 people:

What is the gender of people who have Injection site swelling when taking Mupirocin? *

female: 63.89 %
male: 36.11 %

What is the age of people who have Injection site swelling when taking Mupirocin? *

What are other drugs people take besides Mupirocin? *

What are other side effects people have besides Injection site swelling? *

Injection Site Pain: 18 people, 50.00%
Sinusitis (inflammation of sinus): 12 people, 33.33%
Injection Site Pruritus (severe itching at injection site): 11 people, 30.56%
Injection Site Erythema (redness at injection site): 10 people, 27.78%
Asthma: 8 people, 22.22%
Itching: 7 people, 19.44%
Otitis (ear infection): 6 people, 16.67%
Adverse Drug Reaction: 5 people, 13.89%
Respiratory Disorder (respiratory disease): 5 people, 13.89%
Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 5 people, 13.89%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 16 people, 44.44%
Immunodeficiency Common Variable: 9 people, 25.00%
Stress And Anxiety: 3 people, 8.33%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.33%
Eye Inflammation: 2 people, 5.56%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 5.56%
Sleep Disorder: 2 people, 5.56%
Depression: 2 people, 5.56%
Immune System Disorder: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Mupirocin and have Injection site swelling?

- Check whether Injection site swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mupirocin:

Mupirocin (5,940 reports)

Browse all side effects of Mupirocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site swelling:

Injection site swelling (1,061 drugs)

Browse all the conditions that are associated with Injection site swelling:

Injection site swelling (1,115 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mupirocin (the active ingredients of Mupirocin) and Mupirocin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.